BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 16627303)

  • 1. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.
    Williamson A; Darke S; Ross J; Teesson M
    J Subst Abuse Treat; 2007 Oct; 33(3):287-93. PubMed ID: 17889301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Mills K; Ross J; Darke S; Williamson A; Havard A
    Addiction; 2008 Jan; 103(1):80-8. PubMed ID: 17995994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Teesson M; Ali R; Cooke R; Ritter A; Lynskey M
    J Subst Abuse Treat; 2005 Apr; 28(3):255-63. PubMed ID: 15857726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
    Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
    Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after detoxification for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Havard A; Ross J; Darke S
    Drug Alcohol Rev; 2006 May; 25(3):241-7. PubMed ID: 16753648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study.
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2006 Sep; 84(2):201-5. PubMed ID: 16580792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Mills KL; Williamson A; Havard A; Teesson M
    Addict Behav; 2007 Sep; 32(9):1897-906. PubMed ID: 17289282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia.
    Shearer J; Johnston J; Fry CL; Kaye S; Dillon P; Dietze P; Collins L
    Drug Alcohol Rev; 2007 Sep; 26(5):537-43. PubMed ID: 17701517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.
    Darke S; Ross J; Williamson A; Teesson M
    Addiction; 2005 Aug; 100(8):1121-30. PubMed ID: 16042642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates.
    Mills KL; Lynskey M; Teesson M; Ross J; Darke S
    Drug Alcohol Depend; 2005 Mar; 77(3):243-9. PubMed ID: 15734224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a sustained heroin shortage in three Australian States.
    Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
    Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
    Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission from drug dependence symptoms and drug use cessation among women drug users in puerto rico.
    Warner LA; Alegría M; Canino G
    Arch Gen Psychiatry; 2004 Oct; 61(10):1034-41. PubMed ID: 15466677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2005 May; 78(2):177-86. PubMed ID: 15845321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS).
    Havard A; Teesson M; Darke S; Ross J
    J Subst Abuse Treat; 2006 Jun; 30(4):355-62. PubMed ID: 16716851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes and predictors of change in the physical health status of heroin users over 24 months.
    Williamson A; Darke S; Ross J; Teesson M
    Addiction; 2009 Mar; 104(3):465-70. PubMed ID: 19207357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Rev; 2005 Sep; 24(5):425-32. PubMed ID: 16298837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.